333 related articles for article (PubMed ID: 32671966)
1. Why the elderly appear to be more severely affected by COVID-19: The potential role of immunosenescence and CMV.
Kadambari S; Klenerman P; Pollard AJ
Rev Med Virol; 2020 Sep; 30(5):e2144. PubMed ID: 32671966
[TBL] [Abstract][Full Text] [Related]
2. Immunologic Features in Coronavirus Disease 2019: Functional Exhaustion of T Cells and Cytokine Storm.
Mahmoudi S; Rezaei M; Mansouri N; Marjani M; Mansouri D
J Clin Immunol; 2020 Oct; 40(7):974-976. PubMed ID: 32648027
[No Abstract] [Full Text] [Related]
3. Remodeling of the Immune Response With Aging: Immunosenescence and Its Potential Impact on COVID-19 Immune Response.
Cunha LL; Perazzio SF; Azzi J; Cravedi P; Riella LV
Front Immunol; 2020; 11():1748. PubMed ID: 32849623
[TBL] [Abstract][Full Text] [Related]
4. Targeting T-cell senescence and cytokine storm with rapamycin to prevent severe progression in COVID-19.
Omarjee L; Janin A; Perrot F; Laviolle B; Meilhac O; Mahe G
Clin Immunol; 2020 Jul; 216():108464. PubMed ID: 32405269
[No Abstract] [Full Text] [Related]
5. Racial disparity in Covid-19 mortality rates - A plausible explanation.
Tal Y; Adini A; Eran A; Adini I
Clin Immunol; 2020 Aug; 217():108481. PubMed ID: 32473354
[No Abstract] [Full Text] [Related]
6. Storm of soluble immune checkpoints associated with disease severity of COVID-19.
Kong Y; Wang Y; Wu X; Han J; Li G; Hua M; Han K; Zhang H; Li A; Zeng H
Signal Transduct Target Ther; 2020 Sep; 5(1):192. PubMed ID: 32895366
[No Abstract] [Full Text] [Related]
7. Cellular immune responses to covid-19.
Sewell HF; Agius RM; Stewart M; Kendrick D
BMJ; 2020 Jul; 370():m3018. PubMed ID: 32737031
[No Abstract] [Full Text] [Related]
8. SARS-CoV-2 infection and overactivation of Nlrp3 inflammasome as a trigger of cytokine "storm" and risk factor for damage of hematopoietic stem cells.
Ratajczak MZ; Kucia M
Leukemia; 2020 Jul; 34(7):1726-1729. PubMed ID: 32483300
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 and Hypercoagulability.
Sholzberg M
Clin Adv Hematol Oncol; 2020 Jul; 18(7):386-389. PubMed ID: 32903249
[No Abstract] [Full Text] [Related]
10. Age-Related Differences in Immunological Responses to SARS-CoV-2.
Wong LSY; Loo EXL; Kang AYH; Lau HX; Tambyah PA; Tham EH
J Allergy Clin Immunol Pract; 2020; 8(10):3251-3258. PubMed ID: 32861856
[TBL] [Abstract][Full Text] [Related]
11. Sepsis-associated severe interleukin-6 storm in critical coronavirus disease 2019.
Huang L; Zhao X; Qi Y; Li H; Ye G; Liu Y; Zhang Y; Gou J
Cell Mol Immunol; 2020 Oct; 17(10):1092-1094. PubMed ID: 32917983
[No Abstract] [Full Text] [Related]
12. COVID 19: a clue from innate immunity.
Birra D; Benucci M; Landolfi L; Merchionda A; Loi G; Amato P; Licata G; Quartuccio L; Triggiani M; Moscato P
Immunol Res; 2020 Jun; 68(3):161-168. PubMed ID: 32524333
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 in children: Heterogeneity within the disease and hypothetical pathogenesis.
Suratannon N; Dik WA; Chatchatee P; Hagen PMV
Asian Pac J Allergy Immunol; 2020 Sep; 38(3):170-177. PubMed ID: 32990448
[TBL] [Abstract][Full Text] [Related]
14. The microbial coinfection in COVID-19.
Chen X; Liao B; Cheng L; Peng X; Xu X; Li Y; Hu T; Li J; Zhou X; Ren B
Appl Microbiol Biotechnol; 2020 Sep; 104(18):7777-7785. PubMed ID: 32780290
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 in Africa: Dampening the storm?
Mbow M; Lell B; Jochems SP; Cisse B; Mboup S; Dewals BG; Jaye A; Dieye A; Yazdanbakhsh M
Science; 2020 Aug; 369(6504):624-626. PubMed ID: 32764055
[No Abstract] [Full Text] [Related]
16. Extracorporeal Hemoadsorption: An Option for COVID-19-Associated Cytokine Storm Syndrome.
Napp LC; Bauersachs J
Shock; 2020 Nov; 54(5):700-701. PubMed ID: 32453251
[No Abstract] [Full Text] [Related]
17. Covid-19: Time for a paradigm change.
Buonaguro FM; Ascierto PA; Morse GD; Buonaguro L; Puzanov I; Tornesello ML; Bréchot C; Gallo RC
Rev Med Virol; 2020 Sep; 30(5):e2134. PubMed ID: 32618072
[No Abstract] [Full Text] [Related]
18. Defining the Cytokine Storm Syndrome of COVID-19: Role of the Clinical Laboratory.
Jialal I; Devaraj S
Ann Clin Lab Sci; 2020 Sep; 50(5):703-705. PubMed ID: 33067221
[No Abstract] [Full Text] [Related]
19. Clinical Characteristics and Immune Injury Mechanisms in 71 Patients with COVID-19.
Wu Y; Huang X; Sun J; Xie T; Lei Y; Muhammad J; Li X; Zeng X; Zhou F; Qin H; Shao L; Zhang Q
mSphere; 2020 Jul; 5(4):. PubMed ID: 32669467
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-6 and severe COVID-19: a systematic review and meta-analysis.
Mojtabavi H; Saghazadeh A; Rezaei N
Eur Cytokine Netw; 2020 Jun; 31(2):44-49. PubMed ID: 32933891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
